Nashville, Tenn.-based eyecare pharmaceutical company Harrow has acquired the U.S. commercial rights to five FDA-approved ophthalmic medications from Novartis for $175 million.
Ophthalmology
Clinical trial management company Vial has added retina specialist Veeral Sheth, MD, to its scientific advisory board.
Private equity-backed ophthalmology services provider Vision Innovation Partners has completed four practice acquisitions in 2022, bringing its total number of practices to 24.
Vision Innovation Partners inked a partnership with Chesen Laser Eye Center in Reading, Pa.
Cumming Ophthalmic Research and Development has filed an application for premarket approval with the U.S. Food and Drug Administration for a lens to help treat cataracts.
Advertisement
Atlanta-based ophthalmology management services organization EyeSouth Partners made several moves in 2022, including its acquisition by Olympus Partners and multiple affiliations.
The FDA has issued new draft guidance warning patients about the risks associated with LASIK surgery, according to a Dec. 7 report from the The New York Times.
The University of California Davis Health has opened a 78,500-square-foot eye care center in Sacramento, Calif., as part of an expansion project to its existing ASC.
A branch of the Lord Baltimore Lions Club has made a donation to the Lions Vision Research Center and The Johns Hopkins' Wilmer Eye Institute, both in Baltimore, the Cape Gazette reported Dec. 3.
Stillwater, Minn.-based Associated Eye Care will move to Hudson (Wis.) Medical Center in a three-story building with other businesses, the Star Observer reported Dec. 2.